EDIT Q3 2021 Earnings — Editas Medicine, Inc. Revenue & Financial Results | Market Cap Arena

EDITEditas Medicine, Inc.

$260M

Q3 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$6M-90.1% YoY

Gross Profit

-$23M-372.2% margin

Operating Income

-$39M-633.4% margin

Net Income

-$39M-630.7% margin

EPS (Diluted)

$-0.57

QoQ Revenue Growth

+1535.1%

Cash Flow

Operating Cash Flow

-$41M

Free Cash Flow

-$43M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$717M

Total Liabilities

$130M

Stockholders' Equity

$587M

Cash & Equivalents

$260M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$6M	$63M	-90.1%
Gross Profit	-$23M	$29M	-179.8%
Operating Income	-$39M	$9M	-536.7%
Net Income	-$39M	$8M	-599.8%